HIV Care Retention and Cost Analysis in Multi‐Month ART Dispensing: A Randomized Controlled Trial in China
Journal of the International AIDS Society · 2026-07 · 29 (7)
DOI: 10.1002/jia2.70151 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the International AIDS Society, online erschienen am 24.06.2026. Verfasst von Wenqi Shang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Resea…. Hauptthemen laut MEDLINE: HIV Infections, Retention in Care, Anti-HIV Agents, Anti-Retroviral Agents. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Science and Technology Major Special Project for Prevention and Control of New Emergencies and Major Infectious Diseases, National Key Research and Development Program Project "Establishment and Optimization of Immunotherapy Protocol for HIV Reservoir Clearance", Department of Science and Technology of Liaoning Province Project for the High-Quality Scientific and Technological Development of China Medical University.
Abstract (Originalsprache)
Introduction
Multi‐month dispensing (MMD), as a differentiated service delivery model, can reduce the frequency of clinic visits, waiting time and travel costs for clinically stable people living with HIV. This study aimed to evaluate the impact of 6‐month MMD of antiretroviral therapy (ART) on retention and conduct a cost analysis in China.
Methods
We conducted a randomized, non‐blind, non‐inferiority study from December 2022 to March 2023 at The First Hospital of China Medical University. Eligible participants were randomly assigned to a 3‐month dispensing group ( n = 789) or a 6‐month dispensing group ( n = 799) and followed up for 18 months. The proportion of patients continuing ART after 18 months, virological suppression rate (0.05). In the intention‐to‐treat analysis, treatment retention rates at 18 months were 94.9% (749/789) in the 3‐month dispensing group and 94.2% (753/799) in the 6‐month dispensing group. The risk difference (6‐month minus 3‐month) was −0.7% (95% CI −2.9% to 1.5%); non‐inferiority was demonstrated as the lower bound of the 95% CI (−2.9%) exceeded the pre‐specified margin of −5%. Viral suppression rates (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medica…
Förderung
- the National Science and Technology Major Special Project for Prevention and Control of New Emergencies and Major Infectious Diseases
- National Key Research and Development Program Project "Establishment and Optimization of Immunotherapy Protocol for HIV Reservoir Clearance"
- Department of Science and Technology of Liaoning Province Project for the High-Quality Scientific and Technological Development of China Medical University
- Science and Technology Innovation Team of China Medical University
- Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
Zitieren
APA
Shang, W., Zhu, Y., He, Y., Li, X., Hu, Q., Sun, H., Geng, W., Shang, H., & Ding, H. (2026). HIV Care Retention and Cost Analysis in Multi‐Month ART Dispensing: A Randomized Controlled Trial in China. Journal of the International AIDS Society, 29(7). https://doi.org/10.1002/jia2.70151
Vancouver
Shang W, Zhu Y, He Y, Li X, Hu Q, Sun H, et al. HIV Care Retention and Cost Analysis in Multi‐Month ART Dispensing: A Randomized Controlled Trial in China. Journal of the International AIDS Society. 2026;29(7). doi:10.1002/jia2.70151
BibTeX
@article{Shang2026,
author = {Shang, Wenqi and Zhu, Yanyan and He, Ying and Li, Xiaolin and Hu, Qinghai and Sun, Hong and Geng, Wenqing and Shang, Hong and Ding, Haibo},
title = {HIV Care Retention and Cost Analysis in Multi‐Month ART Dispensing: A Randomized Controlled Trial in China},
journal = {Journal of the International AIDS Society},
year = {2026},
volume = {29},
number = {7},
doi = {10.1002/jia2.70151}
}
EUVIMED